Literature DB >> 8664058

Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta.

P Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, M C Etienne, G Milano, P Pouillart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8664058     DOI： 10.1016/0959-8049(95)00573-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  Osteogenesis Imperfecta/Ehlers-Danlos Overlap Syndrome and Neuroblastoma-Case Report and Review of Literature.

Authors:  Letteria Anna Morabito; Anna Elsa Maria Allegri; Anna Paola Capra; Mario Capasso; Valeria Capra; Alberto Garaventa; Mohamad Maghnie; Silvana Briuglia; Malgorzata Gabriela Wasniewska
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141

2.  Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.

Authors:  S A Ridge; J Sludden; X Wei; A Sapone; O Brown; S Hardy; P Canney; P Fernandez-Salguero; F J Gonzalez; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  Osteogenesis imperfecta, pseudoachalasia, and gastric cancer.

Authors:  Dilsa Mizrak; Ali Alkan; Batuhan Erdogdu; Gungor Utkan
Journal:  Case Rep Gastrointest Med       Date:  2015-03-22

Review 4.  DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.

Authors:  Theodore J Wigle; Elena V Tsvetkova; Stephen A Welch; Richard B Kim
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.